Financing & incentives for neglected disease R&D: Opportunities and challenges

[June 2011]

DNDi is itself an example of a new form of international collaboration in health R&D that has successfully attracted new public and private funding to this field. Both to influence discussions on R&D financing at the WHO and in other fora and to support its own long-term funding strategy, in 2011, DNDi conducted an evaluation on existing and proposed R&D incentives and funding mechanisms, and developed an Outlook piece on the topic.

 

“Financing & incentives for neglected disease R&D: Opportunities and challenges”